[1]
C. Ayón, D. Castán, A. Mora, D. Naranjo, F. Obando, and J. J. Mora, “Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment”, Borneo J Pharm, vol. 5, no. 3, pp. 229–246, Aug. 2022.